The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept
29 December 2021

“Medichronal-Darnitsa” has become No. 1 medication in Ukraine to fight the symptoms of acute alcohol intoxication

29 December 2021

According to calculations of Proxima Research, during the last 12 months almost 700 thousand packages of “Medichronal-Darnitsa” were purchased in Ukrainian pharmacies, which is 70% of the total amount of purchased medications of such type. This is No. 1 medication in Ukraine** in this category.

Taking into account Proxima Research statistics, “Medichronal-Darnitsa”* is most frequently purchased during mass celebrations such as New Year, Christmas and May holidays. For example, Ukrainians bought about 68 thousand packages of the medication in December 2020, more than 76 thousand packages in January 2021, and more than 73 thousand packages in May 2021.

Specialists from the pharmaceutical company “Darnitsa” worked on the “Medichronal” formula together with scientists from the O. V. Palladin Institute of Biochemistry of NAS of Ukraine. From the very beginning, the medication was developed for the treatment of alcohol addiction.

Having proved its effectiveness in therapy, it was approved before its registration in Ukraine with authorization for over-the-counter use to reduce the symptoms of acute alcohol intoxication.

One package of “Medichronal-Darnitsa” consists of two sachets: the components of the medication are specially stored separately in order to ensure storage stability. They should be mixed just before taking them.

Reference

PJSC Pharmaceutical Company “Darnitsa” was founded in 1930. Since 1998, “Darnitsa” has been Ukraine’s leader in the production of medicines in volume terms. The strategic areas of portfolio development are cardiology, neurology and pain management. During 2015-2020, “Darnitsa” has launched 50 pharmaceutical brands on the market.

*Medichronal-Darnitsa, registration certificate No. UA/6504/01/01.

** By sales volume.

The above-stated information is provided solely for distribution in specialized publications intended for medical institutions and physicians, as well as at conferences and seminars on medical topics.

Share:
Specialized edition for medical institutions and doctors.